PET. I can’t see a clear and tangible reason for the decline, but I’m no analyst. Unglamorous but worthy products. Financials look ok. Recently became profitable. Some dilution but cashed up. Directors bought at $0.50 early June. Maybe more to the story that I haven’t picked up on. Only the sovereign risk is stopping me from buying atm.
